A Look At Zylox-Tonbridge Medical Technology (SEHK:2190) Valuation After Investor Open Day Showcases Endovascular Portfolio

Simply Wall St.01-24

Zylox-Tonbridge Medical Technology (SEHK:2190) recently hosted an Investor Open Day at its Zhuhai Innovation Center, showcasing its endovascular product portfolio to nearly 150 institutional investors...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2605323553?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-01-24 15:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605323553","market":"hk","top_or_hot":-1,"title":"A Look At Zylox-Tonbridge Medical Technology (SEHK:2190) Valuation After Investor Open Day Showcases Endovascular Portfolio","media":"Simply Wall St.","content":"<div>\n<p>Zylox-Tonbridge Medical Technology (SEHK:2190) recently hosted an Investor Open Day at its Zhuhai Innovation Center, showcasing its endovascular product portfolio to nearly 150 institutional investors...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-2190/zylox-tonbridge-medical-technology-shares/news/a-look-at-zylox-tonbridge-medical-technology-sehk2190-valuat\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Zylox-Tonbridge Medical Technology (SEHK:2190) Valuation After Investor Open Day Showcases Endovascular Portfolio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Zylox-Tonbridge Medical Technology (SEHK:2190) Valuation After Investor Open Day Showcases Endovascular Portfolio\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-24 15:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/healthcare/hkg-2190/zylox-tonbridge-medical-technology-shares/news/a-look-at-zylox-tonbridge-medical-technology-sehk2190-valuat><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zylox-Tonbridge Medical Technology (SEHK:2190) recently hosted an Investor Open Day at its Zhuhai Innovation Center, showcasing its endovascular product portfolio to nearly 150 institutional investors...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-2190/zylox-tonbridge-medical-technology-shares/news/a-look-at-zylox-tonbridge-medical-technology-sehk2190-valuat\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2190/zylox-tonbridge-medical-technology-shares/news/a-look-at-zylox-tonbridge-medical-technology-sehk2190-valuat","article_id":"2605323553","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2190/zylox-tonbridge-medical-technology-shares/news/a-look-at-zylox-tonbridge-medical-technology-sehk2190-valuat","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2605323553","pubTimestamp":1769239919,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Zylox-Tonbridge Medical Technology (SEHK:2190) recently hosted an Investor Open Day at its Zhuhai Innovation Center, showcasing its endovascular product portfolio to nearly 150 institutional investors and sell side analysts.\nSee our latest analysis for Zylox-Tonbridge Medical Technology.\nThe Investor Open Day comes after a strong run in the shares, with a 30 day share price return of 16.37% and a 1 year total shareholder return of 135.76%. This suggests momentum has been building rather than...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK1100":"医疗保健设备","BK1587":"次新股","BK1574":"生物医药B类股","02190":"归创通桥"},"translate_title":"投资者开放日展示血管内投资组合后Zylox-Tonbridge Medical Technology(SEHK：2190)估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":0.9,"DCF":1},"content_text":"Zylox-Tonbridge Medical Technology (SEHK:2190) recently hosted an Investor Open Day at its Zhuhai Innovation Center, showcasing its endovascular product portfolio to nearly 150 institutional investors and sell side analysts. See our latest analysis for Zylox-Tonbridge Medical Technology. The Investor Open Day comes after a strong run in the shares, with a 30 day share price return of 16.37% and a 1 year total shareholder return of 135.76%. This suggests momentum has been building rather than fading. If events like Zylox Tonbridge’s product showcase have caught your attention, this could be a good moment to scan other healthcare stocks that might fit a similar medical theme. With Zylox Tonbridge growing revenue and net income, and the shares already up sharply over the past year, the key question now is whether the current HK$26.02 price still leaves upside or if the market is already pricing in future growth. AdvertisementPrice to Earnings of 51.4x: Is It Justified? On a P/E of 51.4x at a share price of HK$26.02, Zylox Tonbridge sits at a premium level that immediately stands out against its sector. The P/E ratio compares what investors are paying for each unit of earnings. For a medical equipment company like Zylox Tonbridge, a higher P/E often reflects confidence that earnings can grow meaningfully from here. In this case, earnings are forecast to grow very quickly each year, and the company has already shifted from relatively small profits to much higher profitability recently, which can help explain why the market is willing to pay a higher multiple. Compared with its direct peers, Zylox Tonbridge trades on a lower P/E than the peer average of 54.5x. Within that group it does not look stretched. However, against the wider Hong Kong Medical Equipment industry average of 20.4x, the current 51.4x multiple is more than double. This is a strong signal that the market is pricing in much stronger earnings than the typical company in the sector. Our estimated fair P/E of 25.2x is also far below the current level, suggesting a valuation that could have room to settle closer to that fair ratio if expectations cool. Explore the SWS fair ratio for Zylox-Tonbridge Medical Technology Result: Price-to-Earnings of 51.4x (OVERVALUED) However, the rich 51.4x P/E and recent share price momentum could be vulnerable if revenue or net income growth, around HK$898.46m and HK$152.59m respectively, slows. Find out about the key risks to this Zylox-Tonbridge Medical Technology narrative. Another View: DCF Points the Other Way While the 51.4x P/E suggests Zylox Tonbridge is expensive, our DCF model tells a different story. At HK$26.02, the shares sit around 17.5% below an estimated HK$31.54 future cash flow value. This frames the current price as a potential discount rather than excess. So which signal do you pay more attention to? Look into how the SWS DCF model arrives at its fair value. 2190 Discounted Cash Flow as at Jan 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Zylox-Tonbridge Medical Technology for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 864 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.  Build Your Own Zylox-Tonbridge Medical Technology Narrative If you see the numbers differently or simply prefer to piece together your own view from the raw data, you can build a personalised thesis on Zylox Tonbridge in just a few minutes, starting with Do it your way. A great starting point for your Zylox-Tonbridge Medical Technology research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? If Zylox Tonbridge is already on your radar, do not stop there. Cast a wider net with focused stock lists that can quickly surface fresh opportunities.  Spot potential value with momentum by checking out these 864 undervalued stocks based on cash flows that pair pricing gaps with underlying cash flow support. Ride major technology shifts by scanning these 24 AI penny stocks for companies tied to artificial intelligence themes that could reshape multiple industries. Add a different edge to your watchlist by reviewing these 18 cryptocurrency and blockchain stocks linked to cryptocurrency and blockchain trends that traditional screens might miss.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Zylox-Tonbridge Medical Technology might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605323553","isCrawlerRequest":true}